Srilakshmi Nagendra

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Physical Activity

Bipolar Disorder

Top Venues

Schizophrenia (Heidelberg, Germany)

JMIR formative research

This page only lists publications with an associated author ORCID identifier.

Publications

Asher Cohen, John A Naslund, Sarah Chang, Srilakshmi Nagendra, Anant Bhan, Abhijit Rozatkar, Jagadisha Thirthalli, Ameya Bondre, Deepak Tugnawat, Preethi V Reddy, Siddharth Dutt, Soumya Choudhary, Prabhat Kumar Chand, Vikram Patel, Matcheri Keshavan, Devayani Joshi, Urvakhsh Meherwan Mehta, John B Torous
Relapse prediction in schizophrenia with smartphone digital phenotyping during COVID-19: a prospective, three-site, two-country, longitudinal study. Schizophrenia (Heidelberg, Germany) 9 (1) (2023)
Radhika Suneel Kelkar, Danielle Currey, Srilakshmi Nagendra, Urvakhsh Meherwan Mehta, Vanteemar S Sreeraj, John B Torous, Jagadisha Tirthalli
Utility of Smartphone-Based Digital Phenotyping Biomarkers in Assessing Treatment Response to Transcranial Magnetic Stimulation in Depression: Proof-of-Concept Study. JMIR formative research 7 (2023)
Asher Cohen, John A Naslund, Sarah Chang, Srilakshmi Nagendra, Anant Bhan, Abhijit Rozatkar, Jagadisha Thirthalli, Ameya Bondre, Deepak Tugnawat, Preethi V Reddy, Siddharth Dutt, Soumya Choudhary, Prabhat Kumar Chand, Vikram Patel, Matcheri Keshavan, Devayani Joshi, Urvakhsh Meherwan Mehta, John B Torous
Relapse prediction in schizophrenia with smartphone digital phenotyping during COVID-19: a prospective, three-site, two-country, longitudinal study. Schizophrenia (Heidelberg, Germany) 9 (1) (2023)
Asher Cohen, John A Naslund, Sarah Chang, Srilakshmi Nagendra, Anant Bhan, Abhijit Rozatkar, Jagadisha Thirthalli, Ameya Bondre, Deepak Tugnawat, Preethi V Reddy, Siddharth Dutt, Soumya Choudhary, Prabhat Kumar Chand, Vikram Patel, Matcheri Keshavan, Devayani Joshi, Urvakhsh Meherwan Mehta, John B Torous
Relapse prediction in schizophrenia with smartphone digital phenotyping during COVID-19: a prospective, three-site, two-country, longitudinal study. Schizophrenia (Heidelberg, Germany) 9 (1) (2023)